GlassScriptPhysician profile
Matthew Anders Fuglestad
NPI 1083097836
$3,931.61
in general payments reported to CMS, 2019-2025
7 companies · $1,739 in 2025
The $1,739 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $369 · 2023: $710 · 2024: $1,113 · 2025: $1,739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,801 · Education: $1,000 · Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,801.46 |
| Education | $1,000.00 |
| Food and Beverage | $760.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,294.31 | 2023-2025 | Da Vinci Surgical System |
| Stryker Corporation | $167.86 | 2025 | Spy-Phi System, Sonopet Iq, 1788 |
| Guard Medical INC. | $127.43 | 2022 | |
| Medtronic, INC. | $123.70 | 2022 | |
| Tela Bio, INC. | $100.00 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Zimmer Biomet Holdings, INC. | $60.94 | 2022 | |
| Davol INC. | $57.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Fuglestad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.